U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. For Consumers
  3. Consumer Information by Audience
  4. Minority Health and Health Equity
  5. Enhance EQUITY Initiative
  6. Enhance EQUITY in Clinical Trials
  1. Enhance EQUITY Initiative

Enhance EQUITY in Clinical Trials

Image
Scientist reviewing pictures presented holographically

OMHHE aims to enhance EQUITY in clinical trials by:

  1. Identifying barriers to clinical trial enrollment for underrepresented populations (including, but not limited to, ethnicity, race, age, disability and geography).
  2. Improving data collection and data quality for underrepresented populations in clinical trials.
  3. Employing innovative strategies, trainings, education, and communication methods to increase clinical trial enrollment for underrepresented populations.
  4. Increasing training for diverse clinical trial investigators and other researchers. 

Visit Clinical Trial Diversity for the full list of resources.
 
 

Visit Research and Collaboration for the full list of research projects.

Please sign up for our listserv to learn about future funding opportunities.

Subscribe to the FDA Office of Minority Health and Health Equity email updates

Get regular FDA email updates delivered on this topic to your inbox.

Back to Top